Novo Nordisk supports transparency and is committed to compliance
with disclosing our financial relationships related to our
collaborations with the medical community as required by our industry
guideline, namely the ABPI Code of Practice. We believe transparency
of financial relationships between those with whom we collaborate is
very important to maintaining trust-based relationships with our
patients and the public.
In line with Gender Pay Gap Reporting (GPGR) regulations, all UK companies with more than 250 employees are required to publish their GPGR statistics using data as of 5th April 2022. The metrics cover the gap in pay, the gap in bonus payments, as well as the proportion of genders represented at different pay quartiles, and receiving bonus pay-outs over the previous 12 months period (6 April 2021 to 5 April 2022).
At Novo Nordisk Limited, we are committed to equality, diversity and inclusion across our workforce. We have a number of activities focused on ensuring that employees are paid equally for work of the same value irrespective of gender, and we do not tolerate discrimination on gender or any other protected grounds.